drugset / Trial / NCT05180968
DIalysis Symptom COntrol-Pruritus Outcome Trial
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to test whether or not a medication called nabilone, which is a synthetic (non-natural) medication derived from cannabis, compared to placebo improves symptoms of itch in hemodialysis as measured by visual analog scales.
Timeline
- Start
- 2022-08-02
- Primary completion
- 2023-08-11
- Completion
- 2023-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nabilone | Other / unclassified | 0.5 mg | Oral |